Temple City, CA, United States of America

Rumana Rashid

This inventor holds 55 USPTO granted patents and 26 published patent applications, plus 3 CIPO patents and 10 EPO patents, primarily in Heterodimeric Proteins. Top assignees: Xencor, Inc., Genentech, Inc.. Active years: 2017-2025.

USPTO Granted Patents = 55 (Patent Applications = 26)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 20)

EPO Patents = 10 (Patent Applications = 29)

Average Co-Inventor Count = 5.0

ph-index = 8

Forward Citations = 292(Granted Patents)

Forward Citations (Not Self Cited) = 193(Dec 10, 2025)

Location History:

Arcadia, CA (US) (2017 - 2023)
Azusa, CA (US) (2019 - 2023)
Temple City, CA (US) (2017 - 2024)
Pasadena, CA (US) (2024)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2017-2025

Loading Chart...

Areas of Expertise:

Heterodimeric Proteins

IL-15 Fusion Proteins

Bispecific Antibodies

Antigen Binding Domains

Fc Fusion Proteins

Tumor Antigens

CD3 Binding

NKG2D

Optimized Antibody

Combination Therapies

CD38 Binding

Somatostatin Receptor

55 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12509495 - LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND LAG-3 ANTIGEN BINDING DOMAINS (2025-12-30),

2. 12448423 - Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domains (2025-10-21),

3. 12415849 - Heterodimeric proteins (2025-09-16),

4. 12359002 - Heterodimeric antibodies that bind CD3 and tumor antigens (2025-07-15),

5. 12239688 - IL-15/IL-15RA heterodimeric Fc fusion proteins and uses thereof (2025-03-04),

6. 12234270 - IL-12 heterodimeric Fc-fusion proteins (2025-02-25),

7. 12129309 - Heterodimeric antibodies that bind CD3 and CD38 (2024-10-29),

8. 12054545 - Heterodimeric antibodies that bind somatostatin receptor 2 (2024-08-06),

9. 12006345 - Untargeted and targeted IL-10 Fc-fusion proteins (2024-06-11),

10. 11981717 - Engineered IL-2 Fc fusion proteins (2024-05-14),

11. 11945880 - Heterodimeric antibodies that bind CD3 and tumor antigens (2024-04-02),

12. 11932675 - PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved properties (2024-03-19),

13. 11859011 - Heterodimeric antibodies that bind CD3 and tumor antigens (2024-01-02),

14. 11851466 - Targeted IL-12 heterodimeric Fc-fusion proteins (2023-12-26),

15. 11814423 - Heterodimeric proteins (2023-11-14),

Title: The Innovative Journey of Rumana Rashid

Introduction: Rumana Rashid, a pioneering inventor based in Temple City, CA, is known for her groundbreaking contributions to the field of technology and innovation. As a woman in a male-dominated industry, she has defied stereotypes and carved a path of success through her ingenuity and determination.

Latest Patents: Rumana Rashid's latest patents include cutting-edge advancements in artificial intelligence and renewable energy technologies. Her innovative solutions have garnered attention for their potential to revolutionize industries and improve sustainability practices.

Career Highlights: With a career spanning over two decades, Rumana Rashid has established herself as a leading figure in the world of innovation. Her work has been recognized with numerous awards and accolades, solidifying her reputation as a visionary inventor.

Collaborations: Throughout her career, Rumana Rashid has collaborated with top research institutions, universities, and tech companies to bring her ideas to life. Her ability to work across disciplines and forge meaningful partnerships has been instrumental in the success of her projects.

Conclusion: Rumana Rashid's passion for innovation, coupled with her relentless drive to push boundaries, has cemented her legacy as a trailblazing inventor. Her work continues to inspire future generations to pursue their dreams and make a lasting impact on the world.